BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies

Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...

July 29, 2025 | News

Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals

Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...

July 28, 2025 | News

Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...

July 28, 2025 | News

Clearwater Partners with Google Cloud to Supercharge Healthcare Cybersecurity with Real-Time Threat Intelligence

Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the healthcare industry, today announced a collaboration with Goog...

July 25, 2025 | News

Thermo Fisher Scientific Unveils Breakthrough Electron Microscopes at M&M 2025, Championing Accessibility in Advanced Research

As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at M...

July 25, 2025 | News

Hillhurst Doses First Patient in Phase 2a Trial of Oral CO Therapy for Sickle Cell Disease

Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...

July 24, 2025 | News

New England Biolabs Launches Low-Bias Small RNA Library Prep Kit to Advance RNA Sequencing Accuracy

New England Biolabs (NEB®) nnounced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimize biased representation of s...

July 23, 2025 | News

Community Health Systems to Sell Ambulatory Lab Services to Labcorp for $195 Million in Multi-State Deal

Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a defi...

July 23, 2025 | News

AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in th...

July 22, 2025 | News

TCAI Becomes First in U.S. to Implant Leadless Cardiac Resynchronization Device

Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an F...

July 21, 2025 | News

FDA Pulls Emergency Brake on Sarepta's Gene Therapy Trials Amid Fatal Safety Crisis

The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular dy...

July 21, 2025 | Regulatory

Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...

July 17, 2025 | News

Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System

Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* hel...

July 15, 2025 | News

FDA Publishes First-Ever Public Database of Complete Response Letters (2020–2024) – Now Available for Download

Download Approved CRLs – 2020 to 2024 (external link) U.S. Food and Drug Administration (FDA) has, for the first time, made pub...

July 14, 2025 | Regulatory

Stay Connected